0001437749-13-013018.txt : 20131015 0001437749-13-013018.hdr.sgml : 20131014 20131011200447 ACCESSION NUMBER: 0001437749-13-013018 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06c FILED AS OF DATE: 20131015 DATE AS OF CHANGE: 20131011 EFFECTIVENESS DATE: 20131015 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RESPONSE BIOMEDICAL CORP CENTRAL INDEX KEY: 0000806888 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-204485 FILM NUMBER: 131148876 BUSINESS ADDRESS: STREET 1: 1781 - 75TH AVENUE W. CITY: VANCOUVER STATE: A1 ZIP: V6P6P2 BUSINESS PHONE: 604-456-6010 MAIL ADDRESS: STREET 1: 1781 - 75TH AVENUE W. CITY: VANCOUVER STATE: A1 ZIP: V6P6P2 D 1 primary_doc.xml X0707 D LIVE 0000806888 RESPONSE BIOMEDICAL CORP 1781 - 75TH AVENUE W. VANCOUVER A1 BRITISH COLUMBIA, CANADA V6P6P2 604-456-6010 BRITISH COLUMBIA, CANADA None None Corporation true Jeffrey L. Purvin 1781 - 75th Avenue W Vancouver A1 BRITISH COLUMBIA, CANADA V6P 6P2 Executive Officer Director Anthony F. Holler 1781 - 75th Avenue W Vancouver A1 BRITISH COLUMBIA, CANADA V6P 6P2 Director Joseph D. Keegan 1781 - 75th Avenue W Vancouver A1 BRITISH COLUMBIA, CANADA V6P 6P2 Director Clinton H. Severson 1781 - 75th Avenue W Vancouver A1 BRITISH COLUMBIA, CANADA V6P 6P2 Director Lewis Shuster 1781 - 75th Avenue W Vancouber A1 BRITISH COLUMBIA, CANADA V6P 6P2 Director Peter A. Thompson 1781 - 75th Avenue W Vancouver A1 BRITISH COLUMBIA, CANADA V6P 6P2 Director David Wang 1781 - 75th Avenue W Vancouver A1 BRITISH COLUMBIA, CANADA V6P 6P2 Director William J. Adams 1781 - 75th Avenue W Vancouver A1 BRITISH COLUMBIA, CANADA V6P 6P2 Executive Officer Other Health Care Decline to Disclose 06c false 2013-09-26 false true true true false 0 4000000 3119136 880864 Amounts listed are in Canadian dollars false 10 74295 0 Cash Commission: $30,957; Warrant Commission*: $43,338. *17,689 warrants to purchase common shares @$2.45 per share. Amounts listed are in Canadian Dollars 0 false RESPONSE BIOMEDICAL CORP /s/William J. Adams William J. Adams CFO 2013-10-10